Fintech PR
FalconX and CF Benchmarks Partner to Create Institutional-Grade Derivatives Contracts
Collaboration revolutionizes the cryptocurrency industry by providing
unprecedented access to regulated derivative instruments
LONDON, July 18, 2023 /PRNewswire/ — FalconX, the most reliable digital assets prime brokerage for the world’s leading institutions, is releasing the only crypto derivatives offered by a CFTC-regulated swaps dealer. These contracts are settled against indices administered by CF Benchmarks, the FCA regulated cryptocurrency index provider.
The contracts offer regulated access to the crypto derivatives market, via swaps, options and non-deliverable forwards (NDFs) that settle to single asset reference rates provided by CF Benchmarks.
The contracts provide exposure to bitcoin settled against the CME CF Bitcoin Reference Rate, and to ether settled against the CME CF Ether-Dollar Reference Rate. FalconX is also offering a range of derivatives products, settled against regulated CF Benchmarks single asset reference rates, so clients can gain exposure to other leading cryptocurrencies.
“Derivatives benchmarked against resilient and regulated indices are the primary route institutions take to gain exposure to the crypto asset class,” said Sui Chung, CEO of CF Benchmarks. “We are delighted that FalconX will provide exposure to a host of digital assets through our market-leading benchmarks, including the CME CF BRR. This will encourage further activity in the fastest-growing area of institutional finance today.”
CF Benchmarks is a key part of the crypto market’s infrastructure. Its indices have settled the regulated crypto derivatives contracts from CME since launch in 2017. Through the use of the same spot reference source, FalconX clients can tap into the liquidity complex around the CME CF BRR, that includes the most liquid regulated instruments such as the CME crypto futures and ETFs listed in multiple jurisdictions. This development is poised to have a profound impact on the way institutional investors interact with digital assets, ultimately driving increased adoption and growth within the sector.
By offering a suite of benchmarked derivatives contracts, FalconX and CF Benchmarks are addressing the growing demand for secure and transparent investment products in the rapidly expanding digital asset space. Institutional investors can now confidently gain exposure to cryptocurrencies, knowing they are backed by a regulated and reliable infrastructure. The integration of these benchmark indices into FalconX’s offerings will enable clients to efficiently manage risk and seize opportunities in the burgeoning world of digital finance.
As well as enhancing overall market stability and fostering trust among institutional investors, this partnership paves the way for future innovations in the crypto derivatives landscape. As more institutions embrace digital assets, the collaboration between FalconX and CF Benchmarks will prove instrumental in shaping the trajectory of the industry, ultimately spurring further advancements in technology, regulation, and product offerings.
“Regulated derivatives are critical instruments for institutional investors to safely access digital assets,” said Baris Cetinok, Chief Product Officer of FalconX. “We are proud to be able to deliver the industry’s best in class regulated derivatives offering – purpose built for the world’s leading institutional investors.”
The partnership between FalconX and CF Benchmarks signifies a major milestone in the evolution of the digital asset ecosystem. By equipping clients with the tools and resources required to navigate the ever-changing cryptocurrency landscape, this alliance sets a new standard for transparency, reliability, and innovation in the world of institutional finance.
To learn more about these or other derivatives products offered through FalconX, click here.
About FalconX
FalconX is the largest, most reliable prime brokerage for the world’s leading institutions. We provide the most comprehensive access to the deepest global digital asset liquidity. Through our prime brokerage platform, FalconX 360, investors unlock and scale returns faster and more efficiently than any other platform. Our 24/7 dedicated team for account, operational and trading needs enables investors to navigate dynamic markets around the clock.
The company is backed by investors including Accel, Adams Street Partners, Altimeter Capital, American Express Ventures, B Capital, GIC, Lightspeed Venture Partners, Sapphire Ventures, Thoma Bravo, Tiger Global Management and Wellington Management. FalconX has offices in Silicon Valley, New York, Chicago, Bengaluru, Singapore and Malta. For more information visit falconx.io or follow them on Twitter and LinkedIn.
FalconX Media Contact
[email protected]
About CF Benchmarks
CF Benchmarks is the leading provider of cryptocurrency benchmark indices and is authorized as a registered Benchmark Administrator (FRN 847100) under the UK Benchmarks Regulation (UK BMR). Its benchmark indices are composed of market data from six constituent exchanges and provided through public methodologies and transparent governance, for tracking, valuing and settling risk in cryptocurrency products and services.
CF Benchmarks’ indices underpin 99% of the regulated crypto derivatives market, including all crypto derivatives offered by CME Group and equating to over $550bn of cryptocurrency derivative contracts listed for trading by CME Group and Kraken Futures combined.
CF Benchmarks indices are also used by major asset managers such as BlackRock, Evolve ETFs and Hashdex, to benchmark and value regulated investment funds; and in OTC offerings from major providers like Cumberland and B2C2. Additionally, the indices are integrated into some of the largest crypto products in terms of AuM.
CF Benchmarks Media Contact
[email protected]
“FalconX” is a marketing name for FalconX Limited and its subsidiaries. FalconX offers derivatives products out of subsidiaries Bravo, Golf, and Solios. For information about which legal entities offer trading products and services in your jurisdiction, if you are considering entering into a derivatives transaction, or would like more information, please reach out to your Sales or Trading representative.
Solios, Inc. is registered as a federal money services business with FinCEN. FalconX Bravo, Inc. is provisionally registered with the U.S. Commodities Futures Trading Commission (CFTC) as a swap dealer. Neither FalconX Limited, FalconX Bravo, Inc., nor Solios, Inc. are registered with the Securities & Exchange Commission or the Financial Industry Regulatory Authority.
Logo – https://mma.prnewswire.com/media/1741587/FalconX_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/falconx-and-cf-benchmarks-partner-to-create-institutional-grade-derivatives-contracts-301879109.html
Fintech PR
PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer
BOSTON, Jan. 7, 2025 /PRNewswire/ — PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an expansion of their partnership with Pfizer. The parties will launch a new Antibody-Drug-Conjugate (ADC) collaboration while also expanding their existing $260M AI Lab collaboration, which itself was built upon a successful Generative Chemistry partnership.
The teams will leverage PostEra’s AI platform, Proton, a pioneering innovation in generative chemistry and synthesis-aware design, to advance several programs. These new programs include small molecule therapeutics as well as ADCs, where PostEra will use Proton to optimize properties of payloads.
PostEra will receive an upfront payment of $12M and is eligible to receive additional milestone payments and tiered royalties on any approved products arising out of the collaboration.
Over the last 3 years, as part of the AI Lab, PostEra and Pfizer scientists have partnered closely to advance several small molecule programs. After Pfizer nominated the maximum number of programs, the teams have agreed to expand the collaboration to include additional targets with PostEra receiving additional upfront payment and eligibility for milestones and royalties.
“We’re pleased to significantly expand the use of PostEra’s Proton platform. This builds on peer-reviewed publications with Pfizer validating the real-world impact of AI-driven drug discovery in hitting preclinical milestones faster than anticipated,” said Alpha Lee, Chief Scientific Officer of PostEra. “This third partnership with our long-term collaborators at Pfizer underscores Proton’s depth and strength in making a meaningful impact on real-world drug discovery campaigns,” added Aaron Morris, CEO of PostEra.
About PostEra
PostEra is building a modern 21st century biopharma. We use Proton, our AI platform for medicinal chemistry, to accelerate the discovery of new medicines for patients. PostEra is advancing an internal pipeline while also advancing small molecule programs through partnerships with biopharma. We’ve closed over $1Bn in AI partnerships including 4 multi-year agreements with Pfizer and Amgen. PostEra is also leading an antiviral drug discovery center for pandemic preparedness, funded by one of the largest grants in NIH history.
Logo – https://mma.prnewswire.com/media/1722598/PostEra_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/postera-announces-expansion-to-610m-in-their-ai-drug-discovery-collaboration-with-pfizer-302342058.html
Fintech PR
Radius Global Market Research Acquires Illuminas North America
The partnership combines Radius’s strategic insights framework with Illuminas’s expertise in the technology and financial services sectors, thereby strengthening Radius’s capabilities across B2B and consumer markets.
NEW YORK, Jan. 7, 2025 /PRNewswire/ — Radius Global Market Research, a leading global insights and strategy firm, has announced its acquisition of Illuminas North America, a multidisciplinary research consultancy with headquarters in Austin, Texas. The acquisition strengthens Radius’s ability to deliver actionable insights for its global clients and enhances its expertise in supporting strategic insights needs of clients across industries.
Financial details were not disclosed.
Combining Expertise for Greater Insights
The acquisition integrates Radius’s Brand Growth Navigator framework with Illuminas’s strength in data science and deep expertise with technology and service-related industries. Illuminas is renowned for bridging gaps in customer understanding through tailored, data-driven solutions that illuminate optimal paths to success and drive growth for global brands.
“Illuminas’s proven capabilities in technology-focused research and their expertise in supporting B2B companies make them an ideal partner for Radius,” said Chip Lister, managing director of Radius Global Market Research. “This partnership enhances our ability to deliver insights that address critical business challenges for our clients, especially in industries where technology and innovation are key drivers of success.”
Expanding Capabilities for Clients Worldwide
Founded in 2002, Illuminas North America has built a reputation as a trusted partner for Fortune 500 companies and industry leaders. With deep expertise in technology, financial services, and dynamic global markets, Illuminas employs innovative and foundational research techniques, including quantitative and qualitative tools, to deliver insights that go beyond data to uncover compelling narratives.
“Our partnership with Radius will allow us to expand the reach and impact of our work,” said Jay Shutter, Principal and CEO of Illuminas. “By combining our customer-focused methodologies with Radius’s strategic insights framework, we’ll be better equipped to deliver actionable research that empowers our clients to make confident, informed decisions. This is a tremendous opportunity to enrich the value we provide to clients across the globe.”
Global Reach and Local Expertise
Illuminas North America’s offices in Austin, Texas, and Great Falls, Virginia, will enhance Radius’s ability to deliver insights worldwide. This acquisition follows Radius’s January 2025 acquisition of 7th Sense and its January 2024 acquisition of London-based Strive Insight, further extending the firm’s global footprint. Together, Radius and Illuminas will provide a seamless integration of advanced research tools and industry-specific expertise to support clients in achieving their goals.
About Radius Global Market Research
Founded in 1960, Radius is a full-service marketing research consultancy headquartered in New York City, with offices across the U.S. and globally. Radius supports brand growth through its Brand Growth Navigator framework, helping clients align insights with strategic priorities to maximize ROI. Its expertise spans industries, including technology, financial services, and consumer goods. Visit www.radiusinsights.com for more information.
About Illuminas North America
Illuminas is a strategic market research consultancy founded in 2002, specializing in bridging gaps in customer understanding. Headquartered in Austin, Texas, with an office in Great Falls, Virginia, Illuminas provides customized research solutions using proprietary methodologies to uncover insights for technology, financial services, and hospitality industries. The team combines quantitative and qualitative research methods to deliver insights that empower decision-making and drive business growth. Visit www.us.Illuminas.com for more information.
Logo – https://mma.prnewswire.com/media/2223227/Radius_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/radius-global-market-research-acquires-illuminas-north-america-302344596.html
Fintech PR
Fisher Investments Finalizes Strategic Partnership with Advent and ADIA with Completion of Minority Common Stock Investment
Fisher Investments’ Founder Ken Fisher Maintains Majority Controlling Interest
PLANO, Texas, Jan. 7, 2025 /PRNewswire/ — Fisher Investments (“FI”) announced that Advent International (“Advent”) and a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”) completed a previously announced minority investment in Ken Fisher’s namesake firm, Fisher Investments. The $3 billion common stock investment by Advent and ADIA values FI at $12.75 billion.
The transaction was part of Ken Fisher’s long-term estate planning and ensures FI’s long-term private independence, culture, growth evolution and devotion to exceptional client service. Ken Fisher remains active in his current role as FI’s Executive Chairman and Co-Chief Investment Officer and retains a majority of beneficial ownership and over 70% of voting shares in FI. FI CEO Damian Ornani continues to drive FI’s day-to-day operations and business strategy. In connection with the investment, David Mussafer, a Managing Partner at Advent, has joined the board of directors at FI, and Gabriela Weiss, a Principal at Advent, has joined as a board observer at FI.
As of 12/31/24, FI managed nearly $300 billion for over 170,000 clients globally, including over 130,000 US private clients and 200 of the world’s largest and most well-known institutional clients. This is the first outside investment in FI, with previous ownership solely among family and employees. There is no further FI investment transaction contemplated. The investment in common shares includes neither options nor non-common stock preferences and includes proportional voting to the investors’ beneficial ownership in FI.
Ken Fisher said, “While my health is excellent, this transaction is aimed dually at long-term estate tax and planning purposes should anything untoward happen to me. Advent and ADIA are truly exceptional partners who value us operationally and culturally, and are committed to preserving what differentiates FI in our industry.”
Damian Ornani, longtime FI CEO, said, “We welcome Advent and ADIA’s support of our mission to help more new clients around the world.”
David Mussafer said, “We are thrilled to cement Advent’s partnership with FI at a moment when there is a growing need for the smart, independent and personalized financial expertise that FI is recognized for providing for 45 years. We look forward to closely collaborating with Ken, Damian and the rest of the FI team to support the company’s continued growth, drawing on Advent’s deep expertise in helping financial services companies best capitalize on the opportunities ahead.”
J.P. Morgan Securities LLC and RBC Capital Markets served as joint financial advisors and Paul Hastings served as legal advisor to FI. Ropes & Gray served as legal advisor to Advent. Gibson Dunn served as legal advisor to ADIA.
About Fisher Investments
Founded in 1979, Fisher Investments is an independent, fee-only investment adviser. Fisher Investments and its subsidiaries manage nearly $300 billion across three principal businesses—Institutional, US Private Client, and Private Client International. Founder and Executive Chairman Ken Fisher wrote the Forbes “Portfolio Strategy” column for 32 ½ years until 2017, making him the longest running columnist in its history. He now writes monthly for the New York Post and discreet unique columns in native language, varying by country, in 26 major nations, spanning more countries and more total volume than any other columnist of any type in history. Ken has appeared regularly on major TV news like Fox Business and News, BBN Bloomberg and CNN International. Ken has written 11 investing and finance books, including four New York Times bestsellers. For more information, visit www.fisherinvestments.com.
About Advent International
Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $88.8 billion in assets under management* and have made more than 420 investments across 43 countries.
Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans. We bring hands-on operational expertise to enhance and accelerate businesses.
As one of the largest privately-owned partnerships, our 650+ colleagues leverage the full ecosystem of Advent’s global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals.
To learn more, visit our website connect with us on LinkedIn.
*Advent assets under management (AUM) as of June 30, 2024. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.
About Abu Dhabi Investment Authority
Established in 1976, the Abu Dhabi Investment Authority (“ADIA”) is a globally diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation. For more information, visit www.adia.ae.
Media Contacts
For Fisher Investments
Naj Srinivas
Executive Vice President, Corporate Communications
[email protected]
For Advent International
Leslie Shribman
Head of Communications
[email protected]
For ADIA
Garry Nickson
Corporate Communications & Public Affairs
[email protected]
Logo – https://mma.prnewswire.com/media/2592020/Fisher_Investments_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/fisher-investments-finalizes-strategic-partnership-with-advent-and-adia-with-completion-of-minority-common-stock-investment-302344504.html
-
Fintech PR4 days ago
Bybit x Block Scholes Report: BTC Options Steady with Call-Put Parity, ETH Braces for Short-Term Volatility
-
Fintech PR4 days ago
Artificial Intelligence (AI) in Trading Market to Reach USD 35 Billion by 2030, Growing at a 10% CAGR | Valuates Reports
-
Fintech PR7 days ago
DayOne Launches as an Independent Global Data Center Pioneer Following Series B Funding Closure
-
Fintech PR7 days ago
GES Completes Sale to Truelink Capital
-
Fintech PR5 days ago
Bookkeeping in USA: Empower Business Growth and Success with IBN Technologies
-
Fintech PR7 days ago
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60
-
Fintech PR5 days ago
CUBE COMPLETES ACQUISITION OF THOMSON REUTERS REGULATORY INTELLIGENCE AND ODEN BUSINESSES
-
Fintech PR6 days ago
KuCoin Advances the “Menstrual Equity Project”, Benefiting 4,000 Women in the Bahamas